Braveheart Bio, Inc.

Pharmaceutical company · San Francisco, California, United States · Nasdaq: BRVE

Braveheart Bio, Inc. is a pharmaceutical company headquartered in San Francisco, California, United States. Its shares trade on Nasdaq under the ticker BRVE.

Profile compiled from public records. Is this your company? Request a correction or update

Braveheart Bio at a glance

Typepharmaceutical company

HeadquartersSan Francisco, California, United States

Stock listingNasdaq: BRVE

SEC industryPharmaceutical Preparations

SEC CIK2131524

Frequently asked questions about Braveheart Bio

Where is Braveheart Bio headquartered?

Braveheart Bio, Inc. is headquartered in San Francisco, California, United States.

What does Braveheart Bio do?

Braveheart Bio, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Braveheart Bio a public company?

Yes. Braveheart Bio, Inc. trades on Nasdaq under the ticker BRVE.

Similar companies

Kyntra Bio, Inc.San Francisco, California, United States
Nektar TherapeuticsSan Francisco, California, United States
Olema Pharmaceuticals, Inc.San Francisco, California, United States
GT Biopharma, Inc.San Francisco, California, United States
Delpor, Inc.San Francisco, California, United States
Jaguar Health, Inc.San Francisco, California, United States
Silver Creek Pharmaceuticals, Inc.San Francisco, California, United States
Amarantus Bioscience Holdings, Inc.San Francisco, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences